18.20 USD
↗ 0.20 (1.11%)AT CLOSE (11:59 AM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
18.01
↘ 0.20 (1.07%)
POST MARKET (AS OF 05:51 PM EDT)
Post Market
AS OF 05:51 PM EDT
18.01
↘ 0.20 (1.07%)
Market: CLOSED
Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $18.20. AVTX shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$18.29
High?$18.46
Low?$17.63
Prev. Close?$18.00
Volume?8.6M
Avg. Volume?1.9M
VWAP?$17.99
Rel. Volume?4.54x
Bid / Ask
Bid?$15.50 × 1.0K
Ask?$18.13 × 200
Spread?$2.63
Midpoint?$16.81
Valuation & Ratios
Market Cap?956.7M
Shares Out?52.6M
Float?21.2M
Float %?86.6%
P/E Ratio?N/A
P/B Ratio?14.00
EPS?-$1.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
946.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?13
Piotroski F-Score?0/9Weak
Altman Z-Score?9.93Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?34.93%Squeeze Risk
Short Interest?7.4M
Days to Cover?5.5
Free Float21.2M
Avg Daily Volume1.3M
Settlement Date2026-06-15
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.65Strong
Cash Ratio?2.15Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?14.00HIGH▾
Peers100
S&P13
P/S?16,215.14HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-11.8CHEAP▾
S&P97
EV/Sales?15,791.62HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-124.0%WEAK▾
S&P3
ROA?-84.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$931.7M
Fundamentals ratios updated end of day